Skip to main content
VCbacked
Log inGet Started

Specific Biologics

Toronto, Canada

Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.

$1.3M raised
Mar 2026
Grant
Biotechnology

Top Investors

Creative Destruction Lab (CDL)Lumira VenturesadMare Bio InnovationsGenome CanadaOntario Genomics

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Specific Biologics

How much funding has Specific Biologics raised?
Specific Biologics has raised $1.3M in total funding. The most recent round was Grant. The last funding was announced in March 2026.
Who are Specific Biologics's investors?
Specific Biologics's investors include Creative Destruction Lab (CDL), Lumira Ventures, adMare Bio Innovations, Genome Canada, Ontario Genomics.
Where is Specific Biologics headquartered?
Specific Biologics is headquartered in Toronto, Canada.
What does Specific Biologics do?
Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body.
What stage is Specific Biologics at?
Specific Biologics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Specific Biologics — Funding & Investors." VCBacked, March 18, 2026, https://www.vcbacked.co/company/specific-biologics. Accessed June 4, 2026.
APA
VCBacked. (2026). Specific Biologics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/specific-biologics
Wikipedia (cite web)
{{cite web |title=Specific Biologics — Funding & Investors |url=https://www.vcbacked.co/company/specific-biologics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong